LENZ Therapeutics News

LENZ Therapeutics | EFFECT: Others

Sep 20 06:02 ET

LENZ Therapeutics | 424B3: Prospectus

Sep 19 17:05 ET

LENZ Therapeutics | 424B3: Prospectus

Aug 14 16:32 ET

LENZ Therapeutics | 424B3: Prospectus

Aug 12 08:15 ET

LENZ Therapeutics | 424B3: Prospectus

Jul 15 08:34 ET

LENZ Therapeutics | 424B3: Prospectus

May 9 16:24 ET

LENZ Therapeutics | 424B3: Prospectus

Apr 11 14:36 ET

LENZ Therapeutics | EFFECT: Others

Apr 11 06:05 ET

Graphite Bio | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 8 17:22 ET

Graphite Bio | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 5 06:12 ET

Graphite Bio | EFFECT: Others

Feb 14 06:09 ET

Graphite Bio | 424B3: Prospectus

Feb 13 16:50 ET

Graphite Bio | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Feb 9 17:26 ET

Graphite Bio | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Feb 5 16:59 ET

Graphite Bio | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Jan 18 00:00 ET

Graphite Bio | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 26, 2023 00:00 ET

Graphite Bio | S-4: Registration of securities issued in business combination transactions

Dec 6, 2023 16:57 ET

Graphite Bio | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 15, 2023 17:23 ET

Graphite Bio | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 15, 2023 08:09 ET

Graphite Bio | EFFECT: Others

Jul 29, 2022 00:15 ET